Welfinac-P Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100mg and Paracetamol 325mg, formulated to provide effective relief from pain and inflammation associated with musculoskeletal disorders. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by selectively inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain, swelling, and inflammation. Paracetamol complements this action by providing analgesic and antipyretic effects through central inhibition of prostaglandin synthesis, making the combination suitable for managing mild to moderate pain and fever. Welfinac-P is commonly indicated for conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other inflammatory musculoskeletal disorders. The combination offers enhanced efficacy with a favorable safety profile when used as directed. It is recommended to be taken orally with food to minimize gastrointestinal irritation. Caution is advised in patients with a history of gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs or paracetamol. Welfinac-P should be used under medical supervision, adhering to prescribed dosages to avoid potential adverse effects such as gastrointestinal discomfort, hepatotoxicity, or allergic reactions.